THE FUTURE OF CANCER MEDICINE.... NOW Trademark

Trademark Overview

On Thursday, January 2, 2014, a trademark application was filed for THE FUTURE OF CANCER MEDICINE.... NOW with the United States Patent and Trademark Office. The USPTO has given the THE FUTURE OF CANCER MEDICINE.... NOW trademark a serial number of 86156447. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 18, 2017. The THE FUTURE OF CANCER MEDICINE.... NOW trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

biological research; biotechnology research; medical and scientific research in the field of cancer treatment and diagnosis; pharmaceutical products development; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information in the field of clinical trials; research and development of vaccines and medicines; research and development and consultation related thereto in the field immune therapies for cancer; research and development in the pharmaceutical and biotechnology fields; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; research on the subject of pharmaceuticals; scientific research for medical purposes in the field of immune therapies for cancer
the future of cancer medicine.... now

General Information

Serial Number86156447
Word MarkTHE FUTURE OF CANCER MEDICINE.... NOW
Filing DateThursday, January 2, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 18, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2015

Trademark Statements

Goods and Servicesbiological research; biotechnology research; medical and scientific research in the field of cancer treatment and diagnosis; pharmaceutical products development; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information in the field of clinical trials; research and development of vaccines and medicines; research and development and consultation related thereto in the field immune therapies for cancer; research and development in the pharmaceutical and biotechnology fields; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; research on the subject of pharmaceuticals; scientific research for medical purposes in the field of immune therapies for cancer

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 16, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressBethesda, MD 20814
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressBethesda, MD 20814

Trademark Events

Event DateEvent Description
Monday, September 18, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 18, 2017ABANDONMENT - NO USE STATEMENT FILED
Saturday, January 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 27, 2017EXTENSION 3 GRANTED
Wednesday, January 25, 2017EXTENSION 3 FILED
Wednesday, January 25, 2017TEAS EXTENSION RECEIVED
Wednesday, September 7, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 6, 2016EXTENSION 2 GRANTED
Friday, August 5, 2016EXTENSION 2 FILED
Wednesday, August 31, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 5, 2016TEAS EXTENSION RECEIVED
Thursday, July 21, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 21, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 11, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 9, 2016EXTENSION 1 GRANTED
Tuesday, February 9, 2016EXTENSION 1 FILED
Tuesday, February 9, 2016TEAS EXTENSION RECEIVED
Tuesday, August 18, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 23, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 23, 2015PUBLISHED FOR OPPOSITION
Wednesday, June 3, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 19, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 13, 2015EXPARTE APPEAL TERMINATED
Wednesday, May 13, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 6, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 6, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 4, 2015ASSIGNED TO LIE
Thursday, April 30, 2015TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, April 30, 2015EX PARTE APPEAL-INSTITUTED
Thursday, April 30, 2015JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, April 30, 2015EXPARTE APPEAL RECEIVED AT TTAB
Thursday, October 30, 2014NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, October 30, 2014FINAL REFUSAL E-MAILED
Thursday, October 30, 2014FINAL REFUSAL WRITTEN
Friday, October 10, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 9, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 9, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 9, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 10, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 10, 2014NON-FINAL ACTION E-MAILED
Thursday, April 10, 2014NON-FINAL ACTION WRITTEN
Thursday, April 3, 2014ASSIGNED TO EXAMINER
Thursday, January 16, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 6, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

medicine cancer future research development field scientific medical pharmaceutical pharmaceuticals clinical therapies